Valuation: STCube, Inc.

Market Cap 550B 360M 315M 289M 270M 511M 34.25B 519M 3.47B 1.35B 16.84B 1.35B 1.32B 58.23B P/E 2024
-19.4x
P/E 2025 -25.6x
Enterprise Value 493B 322M 282M 259M 241M 458M 30.68B 465M 3.11B 1.21B 15.08B 1.21B 1.18B 52.15B EV / Sales 2024
44.3x
EV / Sales 2025 71.5x
Free-Float
92.57%
Yield 2024 *
-
Yield 2025 -
24-10-23 STCube, Inc. announced that it has received KRW 13.00000464 billion in funding CI
24-08-25 STCube, Inc. announced that it expects to receive KRW 13.00000464 billion in funding CI
24-03-27 STCube, Inc.(KOSDAQ:A052020) dropped from S&P Global BMI Index CI
23-09-06 Global markets live: Apple, Alphabet, Roku, Amazon, General Mills... Zonebourse
23-03-21 STCube, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
22-03-07 STCube to Raise $36 Million via Stock Sale; Shares Surge 10% MT
20-12-27 STCube, Inc. announced that it has received KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
20-12-17 STCube, Inc. announced that it expects to receive KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
20-07-11 Samsung Biologics Signs Additional Development and Manufacturing Agreement with STCube CI
20-03-02 Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug CI
18-05-24 STCube, Inc. announced that it has received KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm CI
18-04-24 STCube, Inc. announced that it expects to receive KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm and other investors CI
16-09-19 STCube, Inc.(KOSDAQ:A052020) added to S&P Global BMI Index CI
1 day-2.17%
1 week-7.95%
Current month-6.25%
1 month-28.26%
3 months-49.12%
6 months-7.32%
Current year-1.22%
1 week 7,900
Extreme 7900
9,250
1 month 7,900
Extreme 7900
11,750
Current year 6,950
Extreme 6950
22,500
1 year 6,540
Extreme 6540
22,500
3 years 3,940
Extreme 3940
22,500
5 years 3,940
Extreme 3940
28,500
10 years 3,940
Extreme 3940
28,600
Manager TitleAgeSince
Chief Executive Officer 61 2013-03-28
Director of Finance/CFO 54 -
Chief Tech/Sci/R&D Officer 62 2014-02-28
Director TitleAgeSince
Director/Board Member 61 2013-02-28
Director/Board Member 54 2013-02-28
Director/Board Member 62 2014-02-28
Date Insider Type Main position Quantity % Market Cap.
24-12-02Buy

Chief Financial Officer

47,582 0.0730%
24-12-02
Bio Medical Holdings Corp.
BuyCompany 449,447 0.6892%
24-12-02Buy

Chief Technology Officer

164,014 0.2515%
Change 5-day change 1-year change 3-year change Capi.($)
-2.17%-7.95%+20.90%-46.95% 360M
-0.12%+4.15%+40.88%+17.28% 121B
+5.81%-9.93%+418.65%+989.30% 57.54B
-10.86%-6.71%+164.76%+395.13% 50.14B
+1.07%+3.47%+128.47%+221.65% 43.53B
+0.75%+14.81%+133.93%+102.48% 31.75B
-1.38%+4.45%+25.89%+58.87% 30.21B
+1.10%+2.20%-13.14%-37.33% 23.03B
+4.89%+9.81%+95.87%+160.40% 20.4B
+1.11%+2.82%+26.15%+80.24% 20.24B
Average +0.02%+1.36%+104.24%+194.11% 39.8B
Weighted average by Cap. -0.12%+1.33%+125.90%+245.05%

Financials

2024 2025
Net sales 11.3B 7.39M 6.46M 5.94M 5.54M 10.5M 703M 10.65M 71.23M 27.71M 346M 27.72M 27.14M 1.2B 6.98B 4.57M 3.99M 3.67M 3.42M 6.49M 435M 6.59M 44.03M 17.13M 214M 17.14M 16.78M 739M
Net income -21.44B -14.02M -12.26M -11.28M -10.5M -19.91M -1.33B -20.21M -135M -52.58M -656M -52.61M -51.49M -2.27B -21.8B -14.26M -12.47M -11.47M -10.68M -20.25M -1.36B -20.56M -137M -53.47M -667M -53.5M -52.36M -2.31B
Net Debt -79.55B -52.03M -45.5M -41.84M -38.98M -73.9M -4.95B -75.02M -502M -195M -2.43B -195M -191M -8.42B -57.42B -37.55M -32.84M -30.2M -28.14M -53.34M -3.57B -54.15M -362M -141M -1.76B -141M -138M -6.08B
Logo STCube, Inc.
STCube Inc is a Korea-based company mainly engaged in the distribution of lens modules and related components. The Company operates its business through two segments. The Distribution segment is engaged in the industrial lens modules and related parts distribution, basic skin care products distribution and Cynthia basic skin care products manufacture and distribution business. The Biotechnology segment is engaged in the research, development and licensing of immunomodulatory anticancer drug therapeutic candidates.
Employees
13
Date Price Change Volume
26-07-03 ₩8,100.00 -2.17% 234,216
26-07-02 ₩8,280.00 -5.37% 336,347
26-07-01 ₩8,750.00 +1.27% 317,982
26-06-30 ₩8,640.00 -5.05% 193,785
26-06-29 ₩9,100.00 +3.41% 339,672
  1. Stock Market
  2. Stocks
  3. A052020 Stock